1. Introduction {#sec1}
===============

Since ancient times, humans have derived many benefits from medicinal plants. A variety of different medicinal plants have traditionally been used in Asian cultures as medicinal plants to treat cancers \[[@B1]\]. The pharmacological screening of plants is an important mean for the discovery of new, safe, and effective drugs. Over 50,000 plants, possess therapeutic virtues in the world, and about 80% of human use herbal medicines at least once in their life \[[@B2], [@B3]\]. Medicinal plants through the multiplicities of their chemical constituents are important for the discovery of new substances active against tumors and other cancers. Screenings of medicinal plants used as anticancer drugs have provided modern medicine with effective cytotoxic pharmaceuticals. More than 60% of the approved anticancer drugs in the United State of America (from 1983 to 1994) were from natural origin \[[@B4], [@B5]\].

Traditional Korean medicine is widely used in Korea and is the primary health care system for more than 20% of the population \[[@B6], [@B7]\]. As previously emphasized in a regional demographic survey, about 30--40% of the Korean population had used complementary and alternative medicine (including traditional Korean medicine) within a 5-year period \[[@B6], [@B8]\].

In the pharmacopoeia of many countries worldwide including Korea, there is still a serious lack of information on the use of medicinal plants in the treatment of cancer. However, it has been recommended that ethnopharmacological usages such as for immune and skin disorders, inflammatory, infectious, parasitic, and viral diseases should be taken into account when selecting plants used to treat cancer, since these reflect disease states bearing relevance to cancer or cancer-like symptoms \[[@B9], [@B10]\]. In general, leukemia cells are often more sensitive to cytotoxic drugs than adherent cancer cells, making them a suitable tool for primary bioactivity screenings. Hence, the present work was designed to investigate the cytotoxicity of a panel of 280 Korean medicinal plants against human CCRF-CEM leukemia cells. Based on the bioactivity of the extracts, selected phytochemicals of active plants were analyzed in more detail. Genes determining sensitivity or resistance to selected compounds were identified by microarray-based mRNA expression profiles and hierarchical cluster analyses in a panel of tumor cell lines of the National Cancer Institute, USA.

2. Material and Methods {#sec2}
=======================

2.1. Plant Material and Extraction {#sec2.1}
----------------------------------

Medicinal plants used in the present work were collected at different localities of the Republic of Korea and provided by Prof. Ik-Soo Lee (College of Pharmacy, Chonnam National University, Kwangju, South Korea). The plants were identified at the National herbarium, where voucher specimens were deposited under the references numbers (see Supplementary material available online at <http://dx.doi.org/10.1155/2013/341724>). The extraction of the air-dried and powdered plant material was conducted using methanol (HPLC grade) with either ASE 300 (Dionex) or a sonicator (Branson Ultrasonics) at 50°C. The extracts were then conserved at 4°C until further use.

2.2. Cell Culture {#sec2.2}
-----------------

Human CCRF-CEM leukemia cells were obtained from Professor Axel Sauerbrey (University of Jena, Jena, Germany). Cells were maintained in RPMI 1640 containing 100 units/mL penicillin and 100 mg/mL streptomycin and supplemented with heat-inactivated 10% fetal bovine serum (FBS), in a humidified environment at 37°C with 5% CO~2~. Doxorubicin ≥ 98.0% (Sigma-Aldrich, Schnelldorf, Germany) was used as a positive (cytotoxic) control.

2.3. Resazurin Cell Growth Inhibition Assay {#sec2.3}
-------------------------------------------

Alamar Blue or Resazurin (Promega, Mannheim, Germany) reduction assay \[[@B11]\] was used to assess the cytotoxicity of the studied samples. The assay tests cellular viability and mitochondrial function. Briefly, aliquots of 5 × 10^4^ cells/mL were seeded in 96-well plates, and extracts were added immediately. After 24 h incubation, 20 *μ*L resazurin 0.01% w/v solution was added to each well and the plates were incubated at 37°C for 1-2 h. Fluorescence was measured on an automated 96-well Infinite M2000 Pro plate reader (Tecan, Crailsheim, Germany) using an excitation wavelength of 544 nm and an emission wavelength of 590 nm. Doxorubicin was used as positive control. The concentration of DMSO was kept at or below 0.1% in all experiments. Each assay was done at least three times, with three replicates each. All samples were tested at a single concentration of 10 *μ*g/mL.

2.4. COMPARE and Hierarchical Cluster Analysis of mRNA Microarray Data {#sec2.4}
----------------------------------------------------------------------

The mRNA microarray hybridization of the NCI cell line panel has been described \[[@B12], [@B13]\] and the date has been deposited at the NCI website (<http://dtp.nci.nih.gov/>). For hierarchical cluster analysis, objects were classified by calculation of distances according to the closeness of between-individual distances by means of hierarchical cluster analysis. All objects were assembled into a cluster tree (dendrogram). The merging of objects with similar features leads to the formation of a cluster, where the length of the branch indicates the degree of relation. The distance of a subordinate cluster to a superior cluster represents a criterion for the closeness of clusters as well as for the affiliation of single objects to clusters. Thus, objects with tightly related features appear together, while the separation in the cluster tree increases with progressive dissimilarity. Previously, cluster models have been validated for gene expression profiling and for approaching molecular pharmacology of cancer \[[@B12]--[@B14]\]. Hierarchical cluster analyses applying the WARD method were done with the WinSTAT program (Kalmia, Cambridge, MA, USA). Missing values were automatically omitted by the program, and the closeness of two joined objects was calculated by the number of data points they contained. In order to calculate distances between all variables included in the analysis, the program automatically standardizes the variables by transforming the data with a mean = 0 and a variance = 1. For COMPARE analysis, the mRNA expression values of genes of interest and IC~50~ values for selected phytochemicals of the NCI cell lines were selected from the NCI database ([http://dtp.nci.nih.gov/](http://dtp.nci.nih.gov)). The mRNA expression has been determined by microarray analyses as reported \[[@B12]\]. COMPARE analyses were performed by a web-based algorithm ([http://dtp.nci.nih.gov/](http://dtp.nci.nih.gov)) to produce rank-ordered lists of genes expressed in the NCI cell lines. The methodology has been described previously in detail \[[@B15]\]. Briefly, every gene of the NCI microarray database was ranked for similarity of its mRNA expression to the IC~50~ values for the corresponding compound. Scale indices of correlations coefficients (*R*-values) were created. Pearson\'s correlation coefficients with positive algebraic signs indicate that greater mRNA expression in cell lines correlate with enhanced drug resistance, whereas coefficients with negative algebraic signs indicate that greater mRNA expression in cell lines was associated with drug sensitivity. Pearson\'s correlation test and *χ* ^2^ test were implemented into the WinSTAT Program (Kalmia). The one-way ANOVA at 95% confidence level was used for statistical analysis.

3. Results {#sec3}
==========

3.1. Cytotoxic Activity {#sec3.1}
-----------------------

In the present work, we screened 280 plant extracts derived from traditional Korean medicine belonging to 73 plant families and 198 species (see Supplementary Table) for their cytotoxicity against human CCRF-CEM leukemia cells.

The results of the cytotoxicity assay ([Figure 1](#fig1){ref-type="fig"}; Supplementary Table) indicated that is among the 280 studied plant extracts, 58 promoted the growth (% growth \> 100%) of CCRF-CEM cells, while the remaining samples showed various extents of growth inhibition. Out of these extracts, 207 extracts showed no or a weak inhibition of cancer cell proliferation (\<50%) at the tested concentration of 10 *μ*g/mL. However, 13 samples induced the proliferation of less 50% cells (IC~50~ \< 10 *μ*g/mL). These samples included *Sedum middendorffianum*whole plant (15.33%), *Lycoris radiata*underground parts (17.61%), *Camellia japonica*fruits (22.28%), *Myrica rubra*stem-stem bark (27.61%), *Lycoris radiata*leaves (27.73%), *Vitis flexuosa aerial parts*(29.32%), *Sedum takesimense*whole plant (32.39%), *Sorbaria sorbifolia var. stellipila*stems (34.98%), *Isodon japonicus*whole plant (44.15%), *Sageretia theezans*leaves and stems (46.35%), *Rubus corchorifolius* aerial part (46.81%), *Alnus japonica*stem-stem bark (48.43%), and *Meliosma oldhamii*stem-stem bark (49.94%) ([Figure 1](#fig1){ref-type="fig"}). The traditional used and reported bioactivities are compiled in [Table 1](#tab1){ref-type="table"}.

3.2. Cytotoxicity of Phytochemicals Derived from Koran Medicinal Plants {#sec3.2}
-----------------------------------------------------------------------

We searched the literature on the chemical constituents of the cytotoxic Korean plants ([Table 1](#tab1){ref-type="table"}). Subsequently, we mined the NCI database for these compounds. Thirteen compounds with average log~10~IC~50~ values over the entire NCI cell line panel below −4.0 M are depicted in [Figure 2](#fig2){ref-type="fig"}. Hopeaphenol and deoxynarciclasine were the most cytotoxic compounds with log~10~IC~50~ values of 0.346 × 10^−6^ M (=0.346 *μ*M) and 0.233 × 10^−5^ M (=2.33 *μ*M), respectively.

If the average IC~50~ values over the entire range of cell lines were diversified regarding their tumor types, colon cancer and melanoma cell lines were most sensitive towards hopeaphenol, whereas leukemia and kidney cancer cell lines were most resistant ([Figure 3(a)](#fig3){ref-type="fig"}). The cell lines reacted in a different manner towards deoxynarciclasine. Leukemia and colon cancer were most sensitive towards this compound, whereas breast cancer and prostate cancer cell lines were most resistant ([Figure 3(b)](#fig3){ref-type="fig"}).

3.3. Cross-Resistance of the NCI Cell Line Panel towards Hopeaphenol and Deoxynarciclasine {#sec3.3}
------------------------------------------------------------------------------------------

The log~10~IC~50~ values of hopeaphenol and deoxynarciclasine were correlated with clinically well-established anticancer drugs. The cell line panel showed statistically significant correlations between deoxynarciclasine and doxorubicin, daunorubicin, vincristine, paclitaxel, cisplatin, melphalan and carmustin. By contrast, cross-resistance was not found between hopeaphenol and these standard drugs, indicating that hopeaphenol might be useful for the treatment of otherwise drug-resistant tumors ([Table 2](#tab2){ref-type="table"}). Interestingly, an inverse correlation was found between the log~10~IC~50~ values for hopeaphenol and the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib. Such a relationship was not found between deoxynarciclasine and erlotinib ([Table 2](#tab2){ref-type="table"}).

3.4. COMPARE and Hierarchical Cluster Analyses of mRNA Microarray Data {#sec3.4}
----------------------------------------------------------------------

We further investigated the microarray-based transcriptomic mRNA expression by COMPARE analyses to test whether the responses of the tumor cells lines to hopeaphenol and deoxynarciclasine were associated with specific gene expression profiles. For this reason, we mined the transcriptome-wide mRNA expression database of the NCI and correlated the expression data with the IC~50~ values for both compounds. This represents a hypothesis-generating bioinformatical approach, which allows the identification of novel putative molecular determinants of cellular response for hopeaphenol and deoxynarciclasine. The scale rankings of genes obtained by COMPARE computation were subjected to Pearson\'s rank correlation tests. The thresholds for correlation coefficients were *R* \> 0.50 for direct correlations and *R* \< −0.50 for inverse correlations. The genes fulfilling these criteria are shown in [Table 3](#tab3){ref-type="table"} (for hopeaphenol) and [Table 4](#tab4){ref-type="table"} (for deoxynarciclasine). These genes were from diverse functional groups for hopeaphenol ([Table 3](#tab3){ref-type="table"}). For deoxynarciclasine, genes were found involved in transcription (*ILF2, BCLAF1, MATR3, PSPC1, ZBTB11, CNOT8, IKZF5, SF1, EBP*, and *MYBL1*), RNA metabolism (*HNRNPA1, LARS, SFRS1, FARSA, NUDT21, DDX39,*and *SERBP1*), translation (*GOT1, NGDN*), cellular proliferation (*CWF19L1, MKI67, HSPA9, MLF1IP*, and *DCBLD2*), intracellular trafficking (*OPTN, SNX6*, and *RAB11FIP5*), endoplasmic/sarcoplasmic reticulum function (*SLN, DNAJC10, LMAN2L, SEC24D*, and *KDELR2*), signal transduction (*FRAT2, CHUK, GNA12*, and *LPP*), and others.

As a next step, the genes identified by COMPARE analyses and Pearson\'s rank correlation tests were subjected to hierarchical cluster analyses. Only the mRNA expression levels but not the IC~50~ values of the compounds for the cell line panel were used for cluster analyses. Four cluster branches were found in the hopeaphenol-related dendrogram ([Figure 4](#fig4){ref-type="fig"}) and three clusters were obtained in the deoxynarcilasine-related cluster analysis ([Figure 5](#fig5){ref-type="fig"}). Remarkably, the distribution of cell lines sensitive or resistance to both drugs considerably varied between the different clusters of the dendrograms. Since the IC~50~ values of the compounds were not included into the cluster analysis, we could address the question whether the gene expression profiles alone are sufficient to predict sensitivity or resistance of cell lines to the compounds.

As shown in [Table 5](#tab5){ref-type="table"}, the distributions of cell lines sensitive or resistant to hopeaphenol and deoxynarciclasine, respectively, were significantly different between the clusters of the dendrograms, indicating that the expression of these genes was not only responsible for the branching of the dendrograms, but also predicted sensitivity or resistance of these cell lines towards these compounds.

4. Discussion {#sec4}
=============

4.1. Cytotoxic Activity {#sec4.1}
-----------------------

The cytotoxicity observed in *Isodon. japonicus*in this work is in concordance with previous reports. In effect, the cytotoxic effect of *I. japonicus* extract was reported against five human cancer cell lines (IC~50~ values below 10 *μ*g/mL on stomach MKN-45, breast MCF-7, leukemia K562, colon HT29, and lung A549 cell lines) with leukemia K562 (IC~50~ : 2.70 *μ*g/mL) being the most sensitive \[[@B16]\]. Also, the ethanol extract of *Lycors radiata* exhibited significant antiproliferative effect against B16F10 melanoma cells and induced apoptosis through the activation of p38 and AP-1 pathway \[[@B17]\]. The present report, therefore, provides evidence on the activity of *L. radiata* not only against cell lines derived from solid tumors but also derived from the hematopoietic system, that is, CCRF-CEM leukemia cells. *Sorbaria sorbifolia* was cytotoxic towards HepG-2 cells via induction of apoptosis and cell cycle arrest \[[@B18]\], and evidence of this activity towards CCRF-CEM leukemia cells is provided herein.

In the US NCI plant screening program, a crude extract is generally considered to have *in vitro* cytotoxic activity, if the IC~50~ value following incubation between 48 and 72 h is less than 20 *μ*g/mL \[[@B19]\]. In this study, we reduced the cutoff point to 10 *μ*g/mL. All extracts were tested at this concentration and only samples with an inhibitory effect \>50% were considered to have highly promising activities against leukemia cells. Under this condition, 13 samples from 12 medicinal plants ([Figure 1](#fig1){ref-type="fig"}) were identified as promising anticancer products and should be screened for more cancer cell lines. It is noteworthy that only *Lycoris radiata*exhibited a significant (\<50% growth proliferation) activity with both aerial and subterraneal parts, suggesting that different parts of the plant should be considered when screening the cytotoxicity of medicinal plants.

To the best of our knowledge, the cytotoxic effect of several active plants ([Table 1](#tab1){ref-type="table"}) against leukemia cells was reported here for the first time. Nevertheless, some of the analyzed plants contain compounds with known cytotoxicity against cancer cells. In fact, the diarylheptanoids \[1,7-bis-(3,4-dihydroxyphenyl)-heptane-3-*O-*β*-* [d]{.smallcaps}-glucopyranosyl(1→3)-**β**-[d]{.smallcaps}-xylopyranoside; 1,7-bis-(3,4-dihydroxyphenyl)-heptane-3-*O-*β*-* [d]{.smallcaps}-apiofuranosyl(1→6)-**β**-[d]{.smallcaps}-glucopyranoside; 1,7-bis-(3,4-dihydroxyphenyl)-heptane-5-*O-*β*-* [d]{.smallcaps}-glucopyranoside, 1,7-bis-(3,4-dihydroxyphenyl)-5-hydroxyheptane; 1,7-bis-(3,4-dihydroxyphenyl)-heptane-3-one-5-*O*-*β*-[d]{.smallcaps}-glucopyranoside; oregonin; hirsutanonol; hirsutenone; 1,7-bis-(3,4-dihydroxyphenyl)-5-hydroxyheptane-3-*O-*β*-* [d]{.smallcaps}-xylopyranoside and platyphylloside\], isolated from the bark of *A. japonica*, showed cytotoxic activities on human, B16 mouse melanoma cells and SNU-1 gastric cancer cell lines with IC~50~ values varying from 17.02 to 55.47 *μ*M \[[@B20]\]. Interestingly, the extract of the stem bark of this plant exhibited significant antiproliferative activity on leukemia CCRF-CEM cells ([Figure 1](#fig1){ref-type="fig"}), inducing less than 25% growth at 10 *μ*g/mL. In addition, Kim et al. \[[@B21]\] reported the presence of two well-known cytotoxic compounds, betulin and lupeol \[[@B22]\] in the extract of this plant. Apoptosis induction *via* Fas-mediated pathway was also reported in human MCF-7 breast adenocarcinoma cells by prodelphinidin B-2 3,3′-di-*O*-gallate, a constituent of *M. rubra* \[[@B23]\]. The presence of such cytotoxic compounds could explain the good activity of the crude extract of *A. japonica* and *M. rubra.* Similarly, the presence of cytotoxic compounds such as quercetin or ferulic acid \[[@B22]\], in *R. corchorifolius* and*S. middendorffianum*extracts \[[@B24], [@B25]\] and *Sedum takesimense*\[[@B26]\] could also provide some explanation on their antiproliferative potentials. Nonetheless, it is interesting to know that the activity does not only depend on the presence of a cytotoxic substance in a plant, but also their quantities and possible interaction with other plant constituents. For example, cytotoxic compounds such as incanone {known to be active on HL60 leukemia cells (IC~50~ value of 6 **µ**M) \[[@B25]\])} or verbascoside \[[@B27]\] {active on human HEP-2 larynx epidermoid carcinoma, human RD rhabdomyosarcoma and human MCF-7 breast adenocarcinoma cell lines \[[@B28]\]} were reported in *Caryopteris incana.*But extract from *Caryopteris incana* did not show significant activities against CCRF-CEM leukemia cells in the present study.

We screened the NCI database of the Developmental Therapeutics Program of the NCI for the constituents of our panel of Korean medicinal plants. The two most cytotoxic compounds were hopeaphenol and deoxynarciclasine. Both compounds have been previously reported to be cytotoxic \[[@B29]--[@B32]\]. While hopeaphenol\'s activity has been demonstrated in mouse tumors *in vitro* and *in vivo* \[[@B31], [@B32]\], the present investigation shows that this compounds also active against human tumor cells. To the best of our knowledge, the mechanisms of action of these two compounds have not been investigated in the past and are addressed in our analysis for the first time.

4.2. COMPARE and Hierarchical Cluster Analyses of mRNA Microarray Data {#sec4.2}
----------------------------------------------------------------------

To gain insight into possible modes of action of both phytochemicals, we investigated gene expression profiles of the NCI cell line panel. By microarray-based gene expression and COMPARE analyses, we correlated the IC~50~ values for both compounds of 60 tumor cell lines with transcriptomic mRNA expression levels of this cell line panel \[[@B12]\]. This approach has been successfully used to unravel the mode of action of novel compounds \[[@B33]\]. Cluster and COMPARE analyses are also useful for comparing gene expression profiles with IC~50~ values for investigational drugs to identify candidate genes for drug resistance \[[@B34], [@B35]\] and to identify prognostic expression profiles in clinical oncology \[[@B36], [@B37]\].

Eleven genes passing the correlation thresholds of *R* \> 0.5 and *R* \< −0.5 were identified to significantly correlate with sensitivity or resistance to hopeaphenol. Except for fibroblast growth factor 9 \[[@B38]\], none of them have been associated with response of tumor cells to cytostatic drugs. This point of view is supported by the fact that the NCI cell lines did not exert cross-resistance between hopeaphenol and anticancer drugs, such as doxorubicin, vincristine, cisplatin, and others.

The genes correlating with the response of tumor cells to deoxynarciclasine were also not known to confer drug resistance as of yet, but many of them belong to functional groups, which are associated with response to chemotherapy. For example, transcriptional regulation, signal transduction, and cell proliferation are well-known processes influencing the success of cancer chemotherapy \[[@B39]--[@B42]\]. This might also explain why the NCI cell line panel exhibited cross-resistance between deoxynarciclasine and standard chemotherapy. On the other hand, genes involved in cellular trafficking or endoplasmic/sarcoplasmic reticulum functions have not been recognized as possible mechanisms of drug resistance of tumors. This finding merits more detailed investigations in the future.

4.3. Conclusion {#sec4.3}
---------------

The present work provides evidence that some plants derived from Korean medicine could be useful in the treatment of leukemia and supports the advanced investigation of the most active plants extracts. It also provides first pharmacological data on the cytotoxicity of some plants, such as *Adenophora racemosa, Cinnamomum japonicum, Eurya japonica, Sedum middendorffianum,* and *Vitis flexuosa*. The identification of cytotoxic phytochemicals from these plants, for example, hopeaphenol, and deoxynarciclasine, and the investigation of their possible molecular modes of action may foster the development of novel treatment strategies against otherwise drug-resistant and refractory tumors.

Supplementary Material {#supplementary-material-sec}
======================

###### 

Extracts of medicinal plants used in traditional Korean medicine investigated for cytotoxic activity towards cancer cells.

###### 

Click here for additional data file.
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![Cytotoxicity of the 13 most active samples from selected Korean medicinal plants extract (at 10 *μ*g/mL) and doxorubicin (1 *μ*M) on CCRF-CEM leukemia cells. Data with different superscript letters are significantly different (*P* \< 0.05). (See Supplementary Data for the overview of the cytotoxicity of all 280 tested extracts. Are shown mean values ± SD of each five measurements.) The established anticancer drug, doxorubicin was used as positive control (black bar).](ECAM2013-341724.001){#fig1}

![Mean log~10~IC~50~ values for selected phytochemicals derived from Korean medicinal plants for tumor cell lines from the NCI cell line panel.](ECAM2013-341724.002){#fig2}

![Cytotoxic activity of hopeaphenol (a) and deoxynarciclasine (b) towards cell lines of different tumor types (mean ± SD).](ECAM2013-341724.003){#fig3}

![Dendrograms obtained by hierarchical cluster analysis of microarray-based gene expressions for hopeaphenol of the panel of NCI cell lines. The dendrograms were obtained by clustering using the WARD method.](ECAM2013-341724.004){#fig4}

![Dendrograms obtained by hierarchical cluster analysis of microarray-based gene expressions for deoxynarciclasine of the panel of NCI cell lines. The dendrograms were obtained by clustering using the WARD method.](ECAM2013-341724.005){#fig5}

###### 

Korean plants with cytotoxic activity.

  Plants (and family)                                                        Traditional uses                                                                                          Part used                   Previously reported activity of the plant                                                                                                                                                                                                                                                                                                                         Reported chemical constituents
  -------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------- --------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Alnus  japonica*  Steudel (Betulaceae)                                    In oriental traditional medicine as remedies for fever, hemorrhage, diarrhea, and alcoholism \[[@B43]\]   Stems-stem bark             Hepatoprotective and antioxidant activities \[[@B44]\], antiviral activity against the influenza virus \[[@B45]\]                                                                                                                                                                                                                                                 1,7-Bis-(3,4-dihydroxyphenyl)-3-hydroxyheptane-5-*O*-**β**-[D]{.smallcaps}-xylopyranoside; 1,7-bis-(3,4-dihydroxyphenyl)-heptane-3-*O*-*β*-[D]{.smallcaps}-glucopyranosyl(1→3)-**β**-[D]{.smallcaps}-xylopyranoside; 1,7-bis-(3,4-dihydroxyphenyl)-heptane-3-*O*-**β**-[D]{.smallcaps}-apiofuranosyl(1→6)-*β*-[D]{.smallcaps}-glucopyranoside; 1,7-bis-(3,4-dihydroxyphenyl)-heptane-5-*O*-**β**-[D]{.smallcaps}-glucopyranoside; 1,7-bis-(3,4-dihydroxyphenyl)-5-hydroxylheptane; 1,7-bis-(3,4-dihydroxyphenyl)-heptane-3-one-5-*O*-**β**-[D]{.smallcaps}-glucopyranoside; oregonin; hirsutanonol; hirsutenone; platyphylloside \[[@B44]\]; tannins (alnusjaponins A and B); 5-*O*-galloyl-(−)-shikimic acid, 2,3-(*S*)-hexahydroxydiphenoyl-[D]{.smallcaps}-glucose, 4,6-di-*O*-galloyl-[D]{.smallcaps}-glucose, 1,4-di-*O*-galloyl-*β*-[D]{.smallcaps}-glucose, 4,6-(*S*)-valoneoyl-[D]{.smallcaps}-glucose; strictinin; gemin D; pedunculagin; praecoxin A; flosin A; stachyurin; casuarinin \[[@B46]\], lupeol; betulin; betulinic aldehyde; 3-acetoxybetulinic aldehyde, **β**-sitosterol \[[@B45]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Camellia japonica* L.  (Theaceae)                                         Cosmetic protectant to keep the skin and hair healthy and as a soothing agent \[[@B47]\]                  Fruits                      Antibacterial activity \[[@B48]\], inhibitor of human immunodeficiency virus type 1 protease \[[@B49]\], Epstein-Barr virus inhibitor \[[@B50]\], antimetastasis activity \[[@B51]\], antioxidant activity \[[@B52], [@B53]\], inhibitor of human type I procollagen production \[[@B54]\], and antiallergic responses \[[@B55]\], anti-inflammatory \[[@B47]\]   3**β**,18**β**-dihydroxy-28-norolean-12-en-16-one; 18**β**-hydroxy-28-norolean-12-ene-3,16-dione; camelliagenin A, B, and C \[[@B56]\], camellenodiol 3-*O*-**β**-[D]{.smallcaps}-galactopyranosyl(1→2)\[**β**-[D]{.smallcaps}-xylopyranosyl(1→2)-*β*-[D]{.smallcaps}-galactopyranosyl(1→3)\]-*β*-[D]{.smallcaps}-glucuronopyranoside; camellenodiol 3-*O*-4′′-*O*-acetyl-**β**-[D]{.smallcaps}-galactopyranosyl(1→2)\[**β**-[D]{.smallcaps}-xylopyranosyl(1→2)-**β**-[D]{.smallcaps}-galactopyranosyl(1→3)\]-**β**-[D]{.smallcaps}-glucuronopyranoside; camellenodiol 3-*O*-(**β**-[D]{.smallcaps}-galactopyranosyl(1→2)\[**β**-[D]{.smallcaps}-xylopyranosyl(1→2)-**β**-[D]{.smallcaps}-galactopyranosyl(1→3)\]-6′-methoxy-**β**-[D]{.smallcaps}-glucuronopyranoside; maragenin II 3-*O*-(**β**-[D]{.smallcaps}-galactopyranosyl(1→2)\[**β**-[D]{.smallcaps}-xylopyranosyl(1→2)-*β*-[D]{.smallcaps}-galactopyranosyl(1→3)\]-6′-methoxy-**β**-[D]{.smallcaps}-glucuronopyranoside, camellioside A; camellioside B \[[@B57]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Isodon japonicus*  (Burman f.) H. Hara (Labiatae)                         Antibacterial, anti-inflammation, and anthelmintic \[[@B58]\]                                             Whole plant                 Cytotoxicity on K562 human leukemia cells and immunomodulatory activity \[[@B16]\], antibacterial activity for plant constituents \[[@B59]\]                                                                                                                                                                                                                      Isadonol; epinodosin; sodoponin; epinodosinol \[[@B60], [@B61]\]; epinodosin; oridonin; taihangjaponicain A; lushanrubescensin J; bisjaponins A and B \[[@B58]\]; isodonal, trichodonin; nodosin; enmein; oridonin; enmein-3-acetate \[[@B59]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Lycoris  radiata*  (L\'Her.) Herbert  (Amaryllidaceae)                    Laryngeal trouble, furuncle, carbuncle, suppurative wounds \[[@B62]\]                                     Leaves, underground parts   Cytotoxicity against B16F10 melanoma cells \[[@B17]\]                                                                                                                                                                                                                                                                                                             Different types of alkaloids (crinine-type; galanthamine-type; lycorine-type homolycorine-type; tazettine-type; narciclasine-type; and lycorine-type alkaloids); trisphaeridine; galanthine; bicolorine; 11-hydroxyvittatine; 8-*O*-demethymaritidine;*O*-demethylgalanthamine; *O*-demethyllycoramine \[[@B63]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Meliosma  oldhamii*  Miq. ex. Maxim. (Sabiaceae)                          Liver ailments \[[@B64]\]                                                                                 Stems-stem bark             Low Cholinesterase inhibition (12--19% at 5 mg/mL) \[[@B65]\], moderate alpha glucosidase activity \[[@B64]\]                                                                                                                                                                                                                                                     ---
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Myrica  rubra*  Sieb. and Zucc. (Myricaceae)                              Diarrhea; gastroenteritis in China \[[@B66]\]                                                             Stems-stem bark             Antioxidant activity \[[@B67]\]; anti-influenza virus activity \[[@B68]\]                                                                                                                                                                                                                                                                                         Taraxerone; taraxerol; myricadiol; sitosterol; 28-hydroxy-[D]{.smallcaps}-friedoolean-14-en-3-one (); myricanol 5-*O*-*β*-[D]{.smallcaps}-glucopyranosyl-(1→3)-*β*-[D]{.smallcaps}-glucopyranoside; myricanol 5-*O*-*α*-[L]{.smallcaps}-arabinofuranosyl-(1→6)-**β**-[D]{.smallcaps}-glucopyranoside; isomyricanone \[[@B69]\]; cyanidin-3-*O*-glucoside; myricetin; quercetin-3-*O*-rutinoside \[[@B67]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Rubus  corchorifolius*  L. f. (Rosaceae)                                  Stomachache, diarrhea, and dysentery \[[@B18]\]                                                           Whole plant                 Antioxidant activity of essential oil \[[@B70]\]                                                                                                                                                                                                                                                                                                                  *Ent*-kauran-3**β**, 16**β**, 17, 19-tetrol; *ent*-2-carbonyl-16**β**-hydroxy-kauran-17**β**-[D]{.smallcaps}-glucoside \[[@B18]\]; rubusin A; quercetin; kaempferol \[[@B25]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Sageretia  theezans*  (L.) Brongn  (Rhamnaceae)                           Tea materials \[[@B71]\]                                                                                  Leaves, Stems               Antioxidant activity \[[@B72]\]                                                                                                                                                                                                                                                                                                                                   7-*O*-methylmearnsitrin; myricetrin, kaempferol 3-*O*-**α**-[L]{.smallcaps}-rhamnopyranoside, europetin 3-*O*-**α**-[L]{.smallcaps}-rhamnoside, and 7-*O*-methyl quercetin 3-*O*-alpha-[L]{.smallcaps}-rhamnopyranoside; 7-*O*-methylmearnsetin 3-*O*-rhamnoside \[[@B71], [@B72]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Sedum  middendorffianum*Maxim. (Crassulaceae)                             ---                                                                                                       Whole plant                 ---                                                                                                                                                                                                                                                                                                                                                               kaempferol; quercetin; myricetin; arbutin \[[@B24]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Sedum  takesimense*  Nakai (Crassulaceae)                                 ---                                                                                                       Whole plant                 Antioxidant activities \[[@B26]\]                                                                                                                                                                                                                                                                                                                                 Ferulic acid; caffeic acid; gallic acid; methyl gallate; myricetin; quercetin; luteolin; rhodalin; rhodalidin; luteolin-7-*O*-**β**-[D]{.smallcaps}-glucoside; arbutin; 1-(4-hydroxyphenyl)-2-(3,5-dihydroxyphenyl)-2-hydroxyethanone; gossypetin-8-*O*-**β**-[D]{.smallcaps}-xylopyranoside; 2,6-di-*O*-galloylarbutin \[[@B26]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Sorbaria  sorbifolia*  (L.) A. Br. var.  *stellipila*  MAX.  (Rosaceae)   ---                                                                                                       Stems                       Antioxidant activities, cytotoxicity \[[@B73], [@B74]\]                                                                                                                                                                                                                                                                                                           Sutherlandin-5-trans-*p*-coumarate; cardiosdiospermin-5-(4-hydroxy) benzoate \[[@B75]\]; noreugenin; wogonin; 5,7,3′,4′-tetrahydroxy-3-methoxyflavone; protocatechuic acid; benzoic acid; emodin; daucosterol \[[@B76]\]; 5,2′,4′-trihydroxy-6,7,5′-trimethoxyflavone; succinic acid; *p*-hydroxybenzoic acid \[[@B77]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Vitis flexuosa*  Thunb. (Vitaceae)                                        ---                                                                                                       Aerial parts                ---                                                                                                                                                                                                                                                                                                                                                               Flexuosol A; gnetin A; (+)-epsilon-viniferin; vitisin A; hopeaphenol \[[@B78]\]

(---): not reported; the complete list of the tested plants is available in supplementary material.

###### 

Cross-resistance profile of a panel of cell lines towards hopeaphenol and deoxynarciclasine determined by correlating the IC~50~ values by Pearson\'s correlation test.

                 Hopeaphenol   Deoxynarciclasine
  -------------- ------------- -------------------
  Doxorubicin                   
    *R*-value    \<0.30        0.340
    *P*-value    \>0.05        0.010
  Daunorubicin                  
    *R*-value    \<0.30        0.430
    *P*-value    \>0.05        0.001
  Vincristine                   
    *R*-value    \<0.30        0.331
    *P*-value    \>0.05        0.012
  Paclitaxel                    
    *R*-value    \<0.30        0.330
    *P*-value    \>0.05        0.012
  Cisplatin                     
    *R*-value    \<0.30        0.300
    *P*-value    \>0.05        0.020
  Melphalan                     
    *R*-value    \<0.30        0.388
    *P*-value    \>0.05        0.004
  Carmustin                     
    *R*-value    \<0.30        0.394
    *P*-value    \>0.05        0.003
  Erlotinib                     
    *R*-value    −0.353        \>−0.30
    *P*-value    0.004         \>0.05

Pearson\'s rank correlation test.

###### 

Genes identified by standard or reverse COMPARE analyses, whose mRNA expression in a panel of 60 cell lines correlated with IC~50~ values for hopeaphenol.

  Pearson\'s correlation coefficient   Experimental ID   Gene symbol   Name                                                    Function
  ------------------------------------ ----------------- ------------- ------------------------------------------------------- ----------------------------------------------------------
  0.552                                GC63503           HMGN4         High mobility group nucleosomal binding domain 4        Binds nucleosomal DNA
  0.527                                GC190712          UAP1          UDP-N-acetylglucosamine pyrophosphorylase 1             Nucleotidyltransferase
  0.521                                GC45602           TBC1D2        TBC1 domain family, member 2                            GTPase activator
  0.521                                GC188142          ERBB2IP       Erbb2 interacting protein                               Receptor adapter, structural constituent of cytoskeleton
  0.515                                GC26884           PRPS1         Phosphoribosyl pyrophosphate synthetase 1               Involved in nucleotide synthesis
  0.513                                GC38343           CNNTAL1                                                               Unknown
  −0.591                               GC97260           MANBA         Mannosidase, beta A, lysosomal                          Exoglycosidase
  −0.574                               GC73531           FGF9          Fibroblast growth factor 9 (glia-activating factor)     Cell growth and differentiation during development
  −0.534                               GC55495           CYP7B1        Cytochrome P450, family 7, subfamily B, polypeptide 1   Monooxygenase
  −0.516                               GC94617           GABRA3        Gamma-aminobutyric acid (GABA) A receptor, alpha 3      Neurotransmission
  −0.515                               GC184017          HES1          Hairy and enhancer of split 1, (Drosophila)             Transcriptional repressor

Information on gene functions was taken from the OMIM database, NCI, USA, (<http://www.ncbi.nlm.nih.gov/Omim/>) and from the GeneCard database of the Weizmann Institute of Science, Rehovot, Israel (<http://bioinfo.weizmann.ac.il/cards/index.html>).

###### 

Genes identified by standard or reverse COMPARE analyses, whose mRNA expression in a panel of 60 cell lines correlated with IC~50~ values for deoxynarciclasine.

  Pearson\'s correlation coefficient   Experimental ID   Gene symbol   Name                                                                          Function
  ------------------------------------ ----------------- ------------- ----------------------------------------------------------------------------- -------------------------------------------------------------
  0.572                                GC74997           SNAP25        Synaptosomal-associated protein, 25 kDa                                       Regulation of neurotransmitter release
  0.56                                 GC32186           OPTN          Optineurin                                                                    Maintenance of membrane trafficking
  0.557                                GC52658           FAM116B       Family with sequence similarity 116, member B                                 Unknown
  0.531                                GC187393          ZDHHC7        Zinc finger, DHHCtype containing 7                                            Palmitoyltransferase
  0.529                                GC12575           CLEC9A        C-type lectin domain family 9, member A                                       Endocytic receptor for necrotic cells
  0.528                                GC188718          SNX6          Sorting nexin 6                                                               Involved in intracellular trafficking
  0.528                                GC154565          RAB11FIP5     RAB11 family interacting protein 5 (class I)                                  Involved in protein trafficking
  0.527                                GC18484           NTAN 1        N-terminal asparagine amidase                                                 Ubiquitin-dependent turnover of intracellular proteins
  0.526                                GC16433           DNAJC10       DnaJ (Hsp40) homolog, subfamily C, member 10                                  Endoplasmic reticulum cochaperone
  0.524                                GC10009           PCOLCE2       Procollagen C-endopeptidase enhancer 2                                        Binds to procollagens
  0.524                                GC45803           LMAN2L        Lectin, mannose-binding 2-like                                                Regulation of export from the endoplasmic reticulum
  0.524                                GC82947           NGDN          Neuroguidin, EIF4E binding protein                                            Involved in the translational repression
  0.519                                GC75800           SEC24D        SEC24 family, member D (*S.  cerevisiae*)                                     Transport of ER-derived vesicles
  0.517                                GC90440           KDELR2        KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2     Retention of luminal endoplasmic reticulum proteins
  0.514                                GC173264          GNA12         Guanine nucleotide binding protein (G protein) *α*12                          Transducer in transmembrane signaling
  0.512                                GC170473          MYBL1         V-Myb myeloblastosis viral oncogene homolog (avian)-like 1                    Transcriptional activator
  0.512                                GC175225          LPP           LIM domain containing preferred translocation partner in lipoma               Signal transduction from cell adhesion sites to the nucleus
  0.511                                GC14006           ITGB5         Integrin, *β*5                                                                Receptor for fibronectin
  0.509                                GC150035          DCBLD2        Discoidin, CUB, and LCCL domain containing 2                                  Involved in tumor progression
  0.508                                GC73833           NCEH1         Neutral cholesterol ester hydrolase 1                                         Promotes tumor cell migration
  0.507                                GC177466          AHNAK         *AHNAK* nucleoprotein                                                         Involved in neuronal cell differentiation
  0.502                                GC40315           ADAL          Adenosine deaminaselike                                                       Putative nucleoside deaminase
  0.502                                GC28174           MPG           N-methylpurine-DNA glycosylase                                                Hydrolysis of alkylated DNA
  0.501                                GC18079           CR1           Complement component (3b/4b) receptor 1 (Knops blood group)                   Mediates cellular binding of particles and immune complexes
  −0.658                               GC18354           ILF2          Interleukin enhancer binding factor 2, 45 kDa                                 Transcription
  −0.608                               GC44240           NDUFA2        NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8 kDa                  Part of mitochondrial membrane respiratory chain
  −0.605                               GC65788           HNRNPA1       Heterogeneous nuclear ribonucleoprotein A1                                    Involved in RNA replication
  −0.589                               GC43237           CWF19L1       CWF19-like 1, cell cycle control (*S. pombe*)                                 Cell cycle control
  −0.572                               GC174320          BCLAF1        BCL2-associated transcription factor 1                                        Death-promoting transcriptional repressor
  −0.572                               GC40779           LARS          Leucyl-tRNA synthetase                                                        Editing of tRNA
  −0.567                               GC151509          FRAT2         Frequently rearranged in advanced T-cell lymphomas 2                          Wnt signaling regulator
  −0.561                               GC175610          IK            *IK* cytokine, downregulator of HLA II                                        May bind to chromatin
  −0.555                               GC30213           SLN           Sarcolipin                                                                    Sarcoplasmic reticulum proteolipid
  −0.553                               GC162737          ANKHD2                                                                                      Unknown
  −0.552                               GC17532           SFRS28                                                                                      Unknown
  −0.55                                GC185046          SFRS1         Serine/arginine-rich splicing factor 1                                        Splicing regulator
  −0.55                                GC37292           FARSA         Phenylalanyl-tRNA synthetase, *α* subunit                                     Phenylalanine-tRNA ligase
  −0.548                               GC32318           MKI67         Antigen identified by monoclonal antibody Ki-67                               Cell proliferation
  −0.548                               GC149101          MATR3         Matrin 3                                                                      Regulator of transcription
  −0.547                               GC150688          PSPC1         Paraspeckle component 1                                                       Regulator of androgen receptor-mediated gene transcription
  −0.546                               GC80581           ZBTB11        Zinc finger and BTB domain containing 11                                      Regulator of transcription
  −0.546                               GC52470           MLF1IP        MLF1 interacting protein                                                      Involved in mitotic progression
  −0.545                               GC81490           NUDT21        Nudix (nucleoside diphosphate linked moiety X)-type motif 21                  Involved in pre-mRNA 3′-processing
  −0.543                               GC33504           DDX39         DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A                                    Involved in pre-mRNA splicing
  −0.543                               GC35760           NDUGB8                                                                                      Unknown
  −0.539                               GC36766           CHUK          Conserved helix-loop-helix ubiquitous kinase                                  Involved in NF-kappa-B signaling
  −0.538                               GC33463           POLD1         Polymerase (DNA directed), *δ*1, catalytic subunit                            DNA synthesis
  −0.537                               GC83208           SERBP1        SERPINE1 mRNA binding protein 1                                               Regulation of mRNA stability
  −0.536                               GC153558          CNOT8         CCR4-NOT transcription complex, subunit 8                                     Transcription factor
  −0.535                               GC17771           GOT1          Glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)   Involved in amino acid metabolism
  −0.535                               GC43091           NUDCD2        NudC domain containing 2                                                      Unknown
  −0.534                               GC31949           HSPA9         Heat shock 70 kDa protein 9 (mortalin)                                        Control of cell proliferation and cellular aging
  −0.533                               GC91403           IKZF5         IKAROS family zinc finger 5 (Pegasus)                                         Transcriptional repressor
  −0.533                               GC31641           SF1           Splicing factor 1                                                             Transcriptional repressor
  −0.532                               GC161453          KDM2B         Lysine (K)-specific demethylase 2B                                            Histone demethylase
  −0.53                                GC35520           EBP           CCAAT/enhancer binding protein (C/*EBP*), gamma                               Transcription factor
  −0.53                                GC10226           ABCB7         ATP-binding cassette, sub-family B (MDR/TAP), member 7                        Heme transport

Information on gene functions was taken from the OMIM database, NCI, USA, (<http://www.ncbi.nlm.nih.gov/Omim/>) and from the GeneCard database of the Weizmann Institute of Science, Rehovot, Israel (<http://bioinfo.weizmann.ac.il/cards/index.html>).

###### 

Separation of clusters of 60 cancer cell lines obtained by hierarchical cluster analysis for hopeaphenol and deoxynarciclasine. The log~10~ IC~50~ median values (M) of each compound were used as cut-off values to define cell lines as being sensitive or resistant. *P* \> 0.05 was considered as not significant (*χ* ^2^ test).

                      Sensitive   Resistant   *χ* ^2^ test
  ------------------- ----------- ----------- ---------------------
  Hopeaphenol                                 
  Partition\*         \<−5.80     \>−5.80      
  Cluster 1           0           7            
  Cluster 2           0           4            
  Cluster 3           15          0            
  Cluster 4           12          16          *P* = 4.49 × 10^−6^
                                              
  Deoxynarciclasine                           
  Partition\*         \<−6.40     \>−6.40      
  Cluster 1           3           22           
  Cluster 2           13          2            
  Cluster 3           7           0           *P* = 1.76 × 10^−6^

\*log~10~ IC~50~ (M).
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